Viewing Study NCT00695305


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2025-12-26 @ 1:57 AM
Study NCT ID: NCT00695305
Status: COMPLETED
Last Update Posted: 2016-12-01
First Post: 2008-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
Sponsor: GlaxoSmithKline
Organization: